New oral anticoagulants (NOAC) and liver injury
- PMID: 24837361
- DOI: 10.1016/j.jhep.2014.05.010
New oral anticoagulants (NOAC) and liver injury
Comment on
-
Rivaroxaban postmarketing risk of liver injury.J Hepatol. 2014 Aug;61(2):293-300. doi: 10.1016/j.jhep.2014.03.026. Epub 2014 Mar 28. J Hepatol. 2014. PMID: 24681117
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical